This compound is a fluorinated nucleoside analog intermediate, featuring a uracil base attached to a modified ribose sugar with acetyl protecting groups. It is primarily used in the synthesis of nucleoside analogs for pharmaceutical research and manufacturing.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 10212-13-2
(2R,3R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
Pharmaceutical intermediate for nucleoside analogs
((2R,3R,5R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate
Pharmaceutical intermediate for nucleoside analogs
1-O-Acetyl-3,5-bis (4-Chlorobenzoyl)-2-Deoxy-D-ribose
Pharmaceutical intermediate for nucleoside analogs
9-(2-Deoxy-2-fluoroarabinofuranosyl)guanine
Pharmaceutical intermediate for nucleoside analogs
2'-Deoxy-2'-fluorocytidine
pharmaceutical intermediate
Tert-butyl N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]carbamate
Pharmaceutical intermediate
1-(cyclopropylcarbonyl)piperazine hydrochloride
pharmaceutical intermediate
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile
pharmaceutical intermediate
[(2R,3R,4R,5R)-3-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-2-yl]methyl acetate
SGWNQYIJJOVQCM-HJQYOEGKSA-N
CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)F)OC(=O)C
—